{"transactions":[{"id":1832410,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-10T23:36:42.000Z","date":"2023-07-07","kind":"sale","planned":false,"acquired":false,"shares":1880,"price":2.8,"value":5264.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":374722,"source":{"system":"sec-edgar","filing":"0001209191-23-041969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123041969/doc4.xml","form_type":"4"}},{"id":1861256,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-09T23:10:51.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":6106,"price":17.0379,"value":104033.4174,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":376602,"source":{"system":"sec-edgar","filing":"0001209191-23-036051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123036051/doc4.xml","form_type":"4"}},{"id":1861255,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-09T23:10:51.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":2791,"price":17.0368,"value":47549.7088,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":382708,"source":{"system":"sec-edgar","filing":"0001209191-23-036051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123036051/doc4.xml","form_type":"4"}},{"id":1921956,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-11T20:59:18.000Z","date":"2023-04-10","kind":"sale","planned":false,"acquired":false,"shares":1869,"price":19.52,"value":36482.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":382999,"source":{"system":"sec-edgar","filing":"0001209191-23-024026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123024026/doc4.xml","form_type":"4"}},{"id":1940598,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T20:50:07.000Z","date":"2023-03-10","kind":"sale","planned":false,"acquired":false,"shares":19489,"price":20.1973,"value":393625.1797,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I."}],"balance_after":384868,"source":{"system":"sec-edgar","filing":"0001209191-23-020781","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123020781/doc4a.xml","form_type":"4/A","original_submission_date":"2023-03-10"}},{"id":1959583,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:38.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":19486,"price":20.1973,"value":393564.5878,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I."}],"balance_after":384868,"source":{"system":"sec-edgar","filing":"0001209191-23-018064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018064/doc4.xml","form_type":"4"}},{"id":1959582,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:38.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":12103,"price":20.1973,"value":244447.9219,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":404357,"source":{"system":"sec-edgar","filing":"0001209191-23-018064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018064/doc4.xml","form_type":"4"}},{"id":1959581,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:38.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":37229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares released for PSU TSR Grant vested on March 8, 2023."}],"balance_after":416460,"source":{"system":"sec-edgar","filing":"0001209191-23-018064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018064/doc4.xml","form_type":"4"}},{"id":1959580,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:38.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":23120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023."}],"balance_after":379231,"source":{"system":"sec-edgar","filing":"0001209191-23-018064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018064/doc4.xml","form_type":"4"}},{"id":1959579,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:38.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":24672,"price":21.1559,"value":521958.3648,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":356111,"source":{"system":"sec-edgar","filing":"0001209191-23-018064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018064/doc4.xml","form_type":"4"}},{"id":1997055,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-24T01:29:01.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":143100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":143100,"derivative":{"exercise_price":22.6,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":143100},"source":{"system":"sec-edgar","filing":"0001209191-23-012423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123012423/doc4.xml","form_type":"4"}},{"id":1997054,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-24T01:29:01.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":85300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":380783,"source":{"system":"sec-edgar","filing":"0001209191-23-012423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123012423/doc4.xml","form_type":"4"}},{"id":2057956,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-10T21:46:14.000Z","date":"2023-01-06","kind":"sale","acquired":false,"shares":1538,"price":19.95,"value":30683.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes one share acquired on November 15, 2022 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":295483,"source":{"system":"sec-edgar","filing":"0001209191-23-002803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123002803/doc4.xml","form_type":"4"}},{"id":2091439,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-10T00:19:57.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":2543,"price":15.79,"value":40153.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":297020,"source":{"system":"sec-edgar","filing":"0001209191-22-060580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122060580/doc4.xml","form_type":"4"}},{"id":2139640,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-11T21:06:46.000Z","date":"2022-10-06","kind":"tax_withholding","acquired":false,"shares":1296,"price":14.26,"value":18480.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":299563,"source":{"system":"sec-edgar","filing":"0001209191-22-053355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122053355/doc4.xml","form_type":"4"}},{"id":2163513,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-08T22:53:36.000Z","date":"2022-09-06","kind":"tax_withholding","acquired":false,"shares":1772,"price":12.26,"value":21724.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":300859,"source":{"system":"sec-edgar","filing":"0001209191-22-049223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122049223/doc4.xml","form_type":"4"}},{"id":2210263,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-08T20:42:04.000Z","date":"2022-07-06","kind":"tax_withholding","acquired":false,"shares":1296,"price":12.4,"value":16070.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,987 shares acquired on May 13, 2022 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":302631,"source":{"system":"sec-edgar","filing":"0001209191-22-041664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122041664/doc4.xml","form_type":"4"}},{"id":2239457,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:23:44.000Z","date":"2022-06-06","kind":"tax_withholding","acquired":false,"shares":1772,"price":9.5,"value":16834.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":301940,"source":{"system":"sec-edgar","filing":"0001209191-22-035219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122035219/doc4.xml","form_type":"4"}},{"id":2300716,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-08T20:07:34.000Z","date":"2022-04-07","kind":"tax_withholding","acquired":false,"shares":1311,"price":12.73,"value":16689.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":303712,"source":{"system":"sec-edgar","filing":"0001209191-22-023840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122023840/doc4.xml","form_type":"4"}},{"id":2342848,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T22:43:30.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":7081,"price":12.69,"value":89857.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":305023,"source":{"system":"sec-edgar","filing":"0001209191-22-017646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122017646/doc4.xml","form_type":"4"}},{"id":2392766,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T01:57:13.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":298000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":298000,"derivative":{"exercise_price":15.6,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":298000},"source":{"system":"sec-edgar","filing":"0001209191-22-010447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122010447/doc4.xml","form_type":"4"}},{"id":2392765,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-17T01:57:13.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":179400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":312104,"source":{"system":"sec-edgar","filing":"0001209191-22-010447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122010447/doc4.xml","form_type":"4"}},{"id":2440652,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-07T22:37:17.000Z","date":"2022-01-06","kind":"tax_withholding","acquired":false,"shares":1536,"price":13.93,"value":21396.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes one share acquired on November 15, 2021 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":132704,"source":{"system":"sec-edgar","filing":"0001209191-22-002496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122002496/doc4.xml","form_type":"4"}},{"id":2545810,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-08T21:03:34.000Z","date":"2021-10-06","kind":"tax_withholding","acquired":false,"shares":1859,"price":10.2,"value":18961.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":134239,"source":{"system":"sec-edgar","filing":"0001209191-21-060056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121060056/doc4.xml","form_type":"4"}},{"id":2638748,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-09T00:31:25.000Z","date":"2021-07-06","kind":"tax_withholding","acquired":false,"shares":1859,"price":25.06,"value":46586.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":136098,"source":{"system":"sec-edgar","filing":"0001209191-21-046078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121046078/doc4.xml","form_type":"4"}},{"id":2830760,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-27T00:19:05.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":164000,"derivative":{"exercise_price":53.01,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001209191-21-015005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121015005/doc4.xml","form_type":"4"}},{"id":2830759,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-27T00:19:05.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":137273,"source":{"system":"sec-edgar","filing":"0001209191-21-015005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121015005/doc4.xml","form_type":"4"}},{"id":2912833,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-09T00:40:15.000Z","date":"2021-01-06","kind":"tax_withholding","acquired":false,"shares":5411,"price":38.31,"value":207295.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 684 shares acquired on November 13, 2020 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":55273,"source":{"system":"sec-edgar","filing":"0001209191-21-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121002837/doc4.xml","form_type":"4"}},{"id":3112392,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-12T10:59:22.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":19800,"price":35.2828,"value":698599.44,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in the open market at prices ranging from $35.22 to $35.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":27800,"source":{"system":"sec-edgar","filing":"0001209191-20-036174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120036174/doc4.xml","form_type":"4"}},{"id":3112391,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-12T10:59:22.000Z","date":"2020-06-10","kind":"purchase","acquired":true,"shares":8000,"price":36.2853,"value":290282.4,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in the open market at prices ranging from $35.75 to $36.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-20-036174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120036174/doc4.xml","form_type":"4"}},{"id":3315553,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T02:10:57.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-Five percent of the shares subject to the option vest on January 6, 2021 and the remainder vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":300000,"derivative":{"exercise_price":43.35,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-20-002645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120002645/doc4.xml","form_type":"4"}},{"id":3315552,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-09T02:10:57.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of restricted stock units.  Twenty-five percent of the restricted stock units vest on January 6, 2021, and the remainder vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-20-002645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120002645/doc4.xml","form_type":"4"}},{"id":119869,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2019-02-20T20:43:35.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":26682,"price":120.17,"value":3206375.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."}],"balance_after":157962,"source":{"system":"sec-edgar","filing":"0000059478-19-000107","document":"wf-form4a_155069540134470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000107/wf-form4a_155069540134470.xml","form_type":"4/A","original_submission_date":"2019-02-06"}},{"id":119874,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2019-02-20T20:37:53.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":25000,"price":121,"value":3025000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2018."}],"balance_after":132962,"source":{"system":"sec-edgar","filing":"0000059478-19-000103","document":"wf-form4_155069505836534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000103/wf-form4_155069505836534.xml","form_type":"4"}},{"id":120467,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2019-02-07T00:02:55.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":20397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":20397,"derivative":{"exercise_date":"2020-02-01","expiration_date":"2020-02-01","underlying":"Common Stock","underlying_shares":20397},"source":{"system":"sec-edgar","filing":"0000059478-19-000051","document":"wf-form4_154949776150306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000051/wf-form4_154949776150306.xml","form_type":"4"}},{"id":120466,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2019-02-07T00:02:55.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":26681,"price":120.17,"value":3206255.77,"ownership":{"direct":true},"balance_after":157961,"source":{"system":"sec-edgar","filing":"0000059478-19-000051","document":"wf-form4_154949776150306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000051/wf-form4_154949776150306.xml","form_type":"4"}},{"id":120579,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2019-02-05T23:49:33.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":12222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2019-02-01","expiration_date":"2019-02-01","underlying":"Common Stock","underlying_shares":12222},"source":{"system":"sec-edgar","filing":"0000059478-19-000034","document":"wf-form4_154941055968100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000034/wf-form4_154941055968100.xml","form_type":"4"}},{"id":120578,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2019-02-05T23:49:33.000Z","date":"2019-02-01","kind":"tax_withholding","acquired":false,"shares":5476,"price":119.86,"value":656353.36,"ownership":{"direct":true},"balance_after":131280,"source":{"system":"sec-edgar","filing":"0000059478-19-000034","document":"wf-form4_154941055968100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000034/wf-form4_154941055968100.xml","form_type":"4"}},{"id":120577,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2019-02-05T23:49:33.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":12222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136756,"source":{"system":"sec-edgar","filing":"0000059478-19-000034","document":"wf-form4_154941055968100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000034/wf-form4_154941055968100.xml","form_type":"4"}},{"id":128244,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-06-01T20:22:20.000Z","date":"2018-05-31","kind":"sale","acquired":false,"shares":25000,"price":85,"value":2125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.00 to $85.03. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":124534,"source":{"system":"sec-edgar","filing":"0000059478-18-000163","document":"wf-form4_152788452675858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000163/wf-form4_152788452675858.xml","form_type":"4"}},{"id":129299,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2018-05-03T20:26:11.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2018-05-01","expiration_date":"2018-05-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000059478-18-000138","document":"wf-form4_152537915780405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000138/wf-form4_152537915780405.xml","form_type":"4"}},{"id":129298,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-05-03T20:26:11.000Z","date":"2018-05-01","kind":"tax_withholding","acquired":false,"shares":8934,"price":81.07,"value":724279.38,"ownership":{"direct":true},"balance_after":149534,"source":{"system":"sec-edgar","filing":"0000059478-18-000138","document":"wf-form4_152537915780405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000138/wf-form4_152537915780405.xml","form_type":"4"}},{"id":129297,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-05-03T20:26:11.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158468,"source":{"system":"sec-edgar","filing":"0000059478-18-000138","document":"wf-form4_152537915780405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000138/wf-form4_152537915780405.xml","form_type":"4"}},{"id":133026,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2018-02-05T23:12:25.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":21326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2018-02-01","expiration_date":"2018-02-01","underlying":"Common Stock","underlying_shares":21326},"source":{"system":"sec-edgar","filing":"0000059478-18-000060","document":"wf-form4_151787233130801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000060/wf-form4_151787233130801.xml","form_type":"4"}},{"id":133025,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-02-05T23:12:25.000Z","date":"2018-02-01","kind":"tax_withholding","acquired":false,"shares":9512,"price":81.45,"value":774752.4,"ownership":{"direct":true},"balance_after":138468,"source":{"system":"sec-edgar","filing":"0000059478-18-000060","document":"wf-form4_151787233130801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000060/wf-form4_151787233130801.xml","form_type":"4"}},{"id":133024,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-02-05T23:12:25.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":21326,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":147980,"source":{"system":"sec-edgar","filing":"0000059478-18-000060","document":"wf-form4_151787233130801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000060/wf-form4_151787233130801.xml","form_type":"4"}},{"id":133237,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2018-01-31T22:57:41.000Z","date":"2018-01-29","kind":"grant","acquired":true,"shares":12222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":12222,"derivative":{"exercise_date":"2019-02-01","expiration_date":"2019-02-01","underlying":"Common Stock","underlying_shares":12222},"source":{"system":"sec-edgar","filing":"0000059478-18-000034","document":"wf-form4_151743944753235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000034/wf-form4_151743944753235.xml","form_type":"4"}},{"id":133236,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2018-01-31T22:57:41.000Z","date":"2018-01-29","kind":"grant","acquired":true,"shares":12437,"price":87.6,"value":1089481.2,"ownership":{"direct":true},"balance_after":126654,"source":{"system":"sec-edgar","filing":"0000059478-18-000034","document":"wf-form4_151743944753235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000034/wf-form4_151743944753235.xml","form_type":"4"}},{"id":134475,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Restricted Stock Unit","published_at":"2017-12-13T20:05:20.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":34615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":34615,"derivative":{"exercise_date":"2021-12-11","expiration_date":"2021-12-11","underlying":"Common Stock","underlying_shares":34615},"source":{"system":"sec-edgar","filing":"0000059478-17-000251","document":"wf-form4_151319550696770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000251/wf-form4_151319550696770.xml","form_type":"4"}},{"id":140845,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP&Pres, LillyDiab & LillyUSA"}}],"security":"Common Stock","published_at":"2017-05-08T19:44:17.000Z","date":"2017-05-04","kind":"sale","acquired":false,"shares":25000,"price":82.76,"value":2069000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $82.67 to $82.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":114217,"source":{"system":"sec-edgar","filing":"0000059478-17-000144","document":"wf-form4_149427264277920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000144/wf-form4_149427264277920.xml","form_type":"4"}},{"id":144218,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2017-02-03T19:35:58.000Z","date":"2017-02-01","kind":"exercise","acquired":false,"shares":10244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2017-02-01","underlying":"Common Stock","underlying_shares":10244},"source":{"system":"sec-edgar","filing":"0000059478-17-000062","document":"wf-form4_148615054513386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000062/wf-form4_148615054513386.xml","form_type":"4"}},{"id":144217,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2017-02-03T19:35:58.000Z","date":"2017-02-01","kind":"tax_withholding","acquired":false,"shares":4810,"price":77.03,"value":370514.3,"ownership":{"direct":true},"balance_after":139217,"source":{"system":"sec-edgar","filing":"0000059478-17-000062","document":"wf-form4_148615054513386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000062/wf-form4_148615054513386.xml","form_type":"4"}},{"id":144216,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2017-02-03T19:35:58.000Z","date":"2017-02-01","kind":"exercise","acquired":true,"shares":10244,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144027,"source":{"system":"sec-edgar","filing":"0000059478-17-000062","document":"wf-form4_148615054513386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000062/wf-form4_148615054513386.xml","form_type":"4"}},{"id":144450,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2017-01-31T22:51:02.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":21326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":21326,"derivative":{"exercise_date":"2018-02-01","expiration_date":"2018-02-01","underlying":"Common Stock","underlying_shares":21326},"source":{"system":"sec-edgar","filing":"0000059478-17-000028","document":"wf-form4_148590304851291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000028/wf-form4_148590304851291.xml","form_type":"4"}},{"id":144449,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2017-01-31T22:51:02.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":20211,"price":75.38,"value":1523505.18,"ownership":{"direct":true},"balance_after":133783,"source":{"system":"sec-edgar","filing":"0000059478-17-000028","document":"wf-form4_148590304851291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000028/wf-form4_148590304851291.xml","form_type":"4"}},{"id":157058,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2016-02-03T18:46:13.000Z","date":"2016-02-01","kind":"exercise","acquired":false,"shares":10360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2016-02-01","expiration_date":"2016-02-01","underlying":"Common Stock","underlying_shares":10360},"source":{"system":"sec-edgar","filing":"0000059478-16-000290","document":"wf-form4_145452516192048.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000290/wf-form4_145452516192048.xml","form_type":"4"}},{"id":157057,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2016-02-03T18:46:13.000Z","date":"2016-02-01","kind":"tax_withholding","acquired":false,"shares":4872,"price":79.1,"value":385375.2,"ownership":{"direct":true},"balance_after":113572,"source":{"system":"sec-edgar","filing":"0000059478-16-000290","document":"wf-form4_145452516192048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000290/wf-form4_145452516192048.xml","form_type":"4"}},{"id":157056,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2016-02-03T18:46:13.000Z","date":"2016-02-01","kind":"exercise","acquired":true,"shares":10360,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":118444,"source":{"system":"sec-edgar","filing":"0000059478-16-000290","document":"wf-form4_145452516192048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000290/wf-form4_145452516192048.xml","form_type":"4"}},{"id":157352,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2016-01-28T23:45:00.000Z","date":"2016-01-26","kind":"grant","acquired":true,"shares":10244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":10244,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2017-02-01","underlying":"Common Stock","underlying_shares":10244},"source":{"system":"sec-edgar","filing":"0000059478-16-000269","document":"wf-form4_145402468774587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000269/wf-form4_145402468774587.xml","form_type":"4"}},{"id":157351,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2016-01-28T23:45:00.000Z","date":"2016-01-26","kind":"grant","acquired":true,"shares":19953,"price":81.96,"value":1635347.88,"ownership":{"direct":true},"balance_after":108084,"source":{"system":"sec-edgar","filing":"0000059478-16-000269","document":"wf-form4_145402468774587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000269/wf-form4_145402468774587.xml","form_type":"4"}},{"id":158555,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-12-10T19:09:12.000Z","date":"2015-12-09","kind":"sale","acquired":false,"shares":25000,"price":83.88,"value":2097000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $83.66 to $84.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":88131,"source":{"system":"sec-edgar","filing":"0000059478-15-000225","document":"wf-form4_144977454120447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000225/wf-form4_144977454120447.xml","form_type":"4"}},{"id":159582,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Employee stock option 2/06 (right to buy)","published_at":"2015-11-16T20:51:57.000Z","date":"2015-11-12","kind":"exercise","acquired":false,"shares":6928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":56.18,"exercise_date":"2009-02-10","expiration_date":"2016-02-09","underlying":"Common Stock","underlying_shares":6928},"source":{"system":"sec-edgar","filing":"0000059478-15-000193","document":"wf-form4_144770710752228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000193/wf-form4_144770710752228.xml","form_type":"4"}},{"id":159581,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-11-16T20:51:57.000Z","date":"2015-11-12","kind":"tax_withholding","acquired":false,"shares":5579,"price":80.7,"value":450225.3,"ownership":{"direct":true},"balance_after":113131,"source":{"system":"sec-edgar","filing":"0000059478-15-000193","document":"wf-form4_144770710752228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000193/wf-form4_144770710752228.xml","form_type":"4"}},{"id":159580,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-11-16T20:51:57.000Z","date":"2015-11-12","kind":"exercise","acquired":true,"shares":6928,"price":56.18,"value":389215.04,"ownership":{"direct":true},"balance_after":118710,"source":{"system":"sec-edgar","filing":"0000059478-15-000193","document":"wf-form4_144770710752228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000193/wf-form4_144770710752228.xml","form_type":"4"}},{"id":167286,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2015-02-03T20:50:48.000Z","date":"2015-02-01","kind":"exercise","acquired":false,"shares":13990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2015-02-01","expiration_date":"2015-02-01","underlying":"Common Stock","underlying_shares":13990},"source":{"system":"sec-edgar","filing":"0000059478-15-000050","document":"wf-form4_142299663670511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000050/wf-form4_142299663670511.xml","form_type":"4"}},{"id":167285,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-02-03T20:50:48.000Z","date":"2015-02-01","kind":"tax_withholding","acquired":false,"shares":6608,"price":72,"value":475776.0,"ownership":{"direct":true},"balance_after":111782,"source":{"system":"sec-edgar","filing":"0000059478-15-000050","document":"wf-form4_142299663670511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000050/wf-form4_142299663670511.xml","form_type":"4"}},{"id":167284,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-02-03T20:50:48.000Z","date":"2015-02-01","kind":"exercise","acquired":true,"shares":13990,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":118390,"source":{"system":"sec-edgar","filing":"0000059478-15-000050","document":"wf-form4_142299663670511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000050/wf-form4_142299663670511.xml","form_type":"4"}},{"id":167457,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2015-01-30T22:12:27.000Z","date":"2015-01-28","kind":"grant","acquired":true,"shares":10360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":10360,"derivative":{"exercise_date":"2016-02-01","expiration_date":"2016-02-01","underlying":"Common Stock","underlying_shares":10360},"source":{"system":"sec-edgar","filing":"0000059478-15-000020","document":"wf-form4_142265593700407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000020/wf-form4_142265593700407.xml","form_type":"4"}},{"id":167456,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2015-01-30T22:12:27.000Z","date":"2015-01-28","kind":"grant","acquired":true,"shares":30037,"price":70.97,"value":2131725.89,"ownership":{"direct":true},"balance_after":104400,"source":{"system":"sec-edgar","filing":"0000059478-15-000020","document":"wf-form4_142265593700407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000020/wf-form4_142265593700407.xml","form_type":"4"}},{"id":168343,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-12-16T21:04:35.000Z","date":"2014-12-10","kind":"tax_withholding","acquired":false,"shares":5474,"price":72.21,"value":395277.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."}],"balance_after":74363,"source":{"system":"sec-edgar","filing":"0000059478-14-000226","document":"wf-form4a_141876386481023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000226/wf-form4a_141876386481023.xml","form_type":"4/A","original_submission_date":"2014-12-12"}},{"id":168364,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Employee stock option 2/05 (right to buy)","published_at":"2014-12-12T22:06:19.000Z","date":"2014-12-10","kind":"exercise","acquired":false,"shares":7101,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":55.65,"exercise_date":"2008-02-11","expiration_date":"2015-02-10","underlying":"Common Stock","underlying_shares":7101},"source":{"system":"sec-edgar","filing":"0000059478-14-000222","document":"wf-form4_141842196908039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000222/wf-form4_141842196908039.xml","form_type":"4"}},{"id":168363,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-12-12T22:06:19.000Z","date":"2014-12-10","kind":"tax_withholding","acquired":false,"shares":6046,"price":72.21,"value":436581.66,"ownership":{"direct":true},"balance_after":73791,"source":{"system":"sec-edgar","filing":"0000059478-14-000222","document":"wf-form4_141842196908039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000222/wf-form4_141842196908039.xml","form_type":"4"}},{"id":168362,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-12-12T22:06:19.000Z","date":"2014-12-10","kind":"exercise","acquired":true,"shares":7101,"price":55.65,"value":395170.65,"ownership":{"direct":true},"balance_after":79837,"source":{"system":"sec-edgar","filing":"0000059478-14-000222","document":"wf-form4_141842196908039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000222/wf-form4_141842196908039.xml","form_type":"4"}},{"id":169301,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-11-04T20:08:27.000Z","date":"2014-11-03","kind":"sale","acquired":false,"shares":5000,"price":66.03,"value":330150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2014."}],"balance_after":72736,"source":{"system":"sec-edgar","filing":"0000059478-14-000181","document":"wf-form4_141513169758618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000181/wf-form4_141513169758618.xml","form_type":"4"}},{"id":169969,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-10-03T15:12:50.000Z","date":"2014-10-01","kind":"sale","acquired":false,"shares":5000,"price":64.86,"value":324300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $64.75 to $65.06. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":77736,"source":{"system":"sec-edgar","filing":"0000059478-14-000157","document":"wf-form4_141234916007183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000157/wf-form4_141234916007183.xml","form_type":"4"}},{"id":170521,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-09-03T15:42:54.000Z","date":"2014-09-02","kind":"sale","acquired":false,"shares":5000,"price":63.6,"value":318000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2014."}],"balance_after":82736,"source":{"system":"sec-edgar","filing":"0000059478-14-000147","document":"wf-form4_140975896339125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000147/wf-form4_140975896339125.xml","form_type":"4"}},{"id":171525,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-07-28T19:16:01.000Z","date":"2014-07-25","kind":"sale","acquired":false,"shares":10000,"price":63.79,"value":637900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $63.72 to $63.84. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":87736,"source":{"system":"sec-edgar","filing":"0000059478-14-000133","document":"wf-form4_140657495079866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000133/wf-form4_140657495079866.xml","form_type":"4"}},{"id":176832,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2014-02-04T15:25:55.000Z","date":"2014-02-01","kind":"exercise","acquired":false,"shares":15674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2014-02-01","expiration_date":"2014-02-01","underlying":"Common Stock","underlying_shares":15674},"source":{"system":"sec-edgar","filing":"0000059478-14-000059","document":"wf-form4_139152754455047.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000059/wf-form4_139152754455047.xml","form_type":"4"}},{"id":176831,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-02-04T15:25:55.000Z","date":"2014-02-01","kind":"tax_withholding","acquired":false,"shares":7363,"price":54.01,"value":397675.63,"ownership":{"direct":true},"balance_after":97736,"source":{"system":"sec-edgar","filing":"0000059478-14-000059","document":"wf-form4_139152754455047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000059/wf-form4_139152754455047.xml","form_type":"4"}},{"id":176830,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-02-04T15:25:55.000Z","date":"2014-02-01","kind":"exercise","acquired":true,"shares":15674,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105099,"source":{"system":"sec-edgar","filing":"0000059478-14-000059","document":"wf-form4_139152754455047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000059/wf-form4_139152754455047.xml","form_type":"4"}},{"id":177064,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2014-01-31T01:29:46.000Z","date":"2014-01-28","kind":"grant","acquired":true,"shares":13990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":13990,"derivative":{"exercise_date":"2015-02-01","expiration_date":"2015-02-01","underlying":"Common Stock","underlying_shares":13990},"source":{"system":"sec-edgar","filing":"0000059478-14-000028","document":"wf-form4_139113177496754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000028/wf-form4_139113177496754.xml","form_type":"4"}},{"id":177063,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2014-01-31T01:29:46.000Z","date":"2014-01-28","kind":"grant","acquired":true,"shares":32248,"price":54.23,"value":1748809.04,"ownership":{"direct":true},"balance_after":89425,"source":{"system":"sec-edgar","filing":"0000059478-14-000028","document":"wf-form4_139113177496754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000028/wf-form4_139113177496754.xml","form_type":"4"}},{"id":181421,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-08-16T15:18:13.000Z","date":"2013-08-15","kind":"sale","acquired":false,"shares":5000,"price":53.79,"value":268950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013."}],"balance_after":57177,"source":{"system":"sec-edgar","filing":"0001209191-13-041072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113041072/doc4.xml","form_type":"4"}},{"id":182713,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-07-15T20:23:55.000Z","date":"2013-07-15","kind":"sale","acquired":false,"shares":5000,"price":51.43,"value":257150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013."}],"balance_after":62177,"source":{"system":"sec-edgar","filing":"0001209191-13-036637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113036637/doc4.xml","form_type":"4"}},{"id":183288,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-06-18T14:34:17.000Z","date":"2013-06-17","kind":"sale","acquired":false,"shares":5000,"price":52.45,"value":262250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013."}],"balance_after":67177,"source":{"system":"sec-edgar","filing":"0001209191-13-032601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113032601/doc4.xml","form_type":"4"}},{"id":184162,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-05-16T20:06:28.000Z","date":"2013-05-15","kind":"sale","acquired":false,"shares":5000,"price":56.15,"value":280750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013."}],"balance_after":72177,"source":{"system":"sec-edgar","filing":"0001209191-13-026800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113026800/doc4.xml","form_type":"4"}},{"id":184866,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2013-05-01T19:46:20.000Z","date":"2013-05-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2013-05-01","expiration_date":"2013-05-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-13-023302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113023302/doc4.xml","form_type":"4"}},{"id":184865,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-05-01T19:46:20.000Z","date":"2013-05-01","kind":"tax_withholding","acquired":false,"shares":4698,"price":55.38,"value":260175.24,"ownership":{"direct":true},"balance_after":77177,"source":{"system":"sec-edgar","filing":"0001209191-13-023302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113023302/doc4.xml","form_type":"4"}},{"id":184864,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-05-01T19:46:20.000Z","date":"2013-05-01","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81875,"source":{"system":"sec-edgar","filing":"0001209191-13-023302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113023302/doc4.xml","form_type":"4"}},{"id":185480,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-04-16T15:46:26.000Z","date":"2013-04-15","kind":"sale","acquired":false,"shares":5000,"price":57.1,"value":285500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $57.09 to $57.14.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":71875,"source":{"system":"sec-edgar","filing":"0001209191-13-021441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113021441/doc4.xml","form_type":"4"}},{"id":187472,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2013-02-04T21:23:27.000Z","date":"2013-02-01","kind":"exercise","acquired":false,"shares":31768,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2013-02-01","expiration_date":"2013-02-01","underlying":"Common Stock","underlying_shares":31768},"source":{"system":"sec-edgar","filing":"0001209191-13-005976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113005976/doc4.xml","form_type":"4"}},{"id":187471,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-02-04T21:23:27.000Z","date":"2013-02-01","kind":"tax_withholding","acquired":false,"shares":14922,"price":53.69,"value":801162.18,"ownership":{"direct":true},"balance_after":76875,"source":{"system":"sec-edgar","filing":"0001209191-13-005976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113005976/doc4.xml","form_type":"4"}},{"id":187470,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-02-04T21:23:27.000Z","date":"2013-02-01","kind":"exercise","acquired":true,"shares":31768,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91797,"source":{"system":"sec-edgar","filing":"0001209191-13-005976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113005976/doc4.xml","form_type":"4"}},{"id":187802,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Restricted Stock Unit","published_at":"2013-01-29T22:00:17.000Z","date":"2013-01-25","kind":"grant","acquired":true,"shares":15674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":15674,"derivative":{"exercise_date":"2014-02-01","expiration_date":"2014-02-01","underlying":"Common Stock","underlying_shares":15674},"source":{"system":"sec-edgar","filing":"0001209191-13-005008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113005008/doc4.xml","form_type":"4"}},{"id":187801,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2013-01-29T22:00:17.000Z","date":"2013-01-25","kind":"grant","acquired":true,"shares":33017,"price":53.21,"value":1756834.57,"ownership":{"direct":true},"balance_after":60029,"source":{"system":"sec-edgar","filing":"0001209191-13-005008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919113005008/doc4.xml","form_type":"4"}},{"id":192039,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2012-08-01T19:13:42.000Z","date":"2012-08-01","kind":"sale","acquired":false,"shares":5000,"price":44.16,"value":220800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012."}],"balance_after":27012,"source":{"system":"sec-edgar","filing":"0001209191-12-039819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112039819/doc4.xml","form_type":"4"}},{"id":192687,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2012-07-03T19:34:26.000Z","date":"2012-07-02","kind":"sale","acquired":false,"shares":5000,"price":43,"value":215000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012."}],"balance_after":32012,"source":{"system":"sec-edgar","filing":"0001209191-12-036813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112036813/doc4.xml","form_type":"4"}},{"id":193101,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2012-06-04T19:52:00.000Z","date":"2012-06-01","kind":"sale","acquired":false,"shares":5000,"price":40.6,"value":203000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012."}],"balance_after":37012,"source":{"system":"sec-edgar","filing":"0001209191-12-031898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112031898/doc4.xml","form_type":"4"}},{"id":193928,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2012-05-02T14:09:37.000Z","date":"2012-05-01","kind":"sale","acquired":false,"shares":5000,"price":41.32,"value":206600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012."}],"balance_after":42012,"source":{"system":"sec-edgar","filing":"0001209191-12-025306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112025306/doc4.xml","form_type":"4"}},{"id":194447,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12020,"kind":"person","name":"Conterno Enrique A","position":1,"cik":"0001476151","reported_name":"Conterno Enrique A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Pres., Lilly Diabetes"}}],"security":"Common Stock","published_at":"2012-04-04T17:37:03.000Z","date":"2012-04-02","kind":"sale","acquired":false,"shares":5000,"price":40.3,"value":201500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012."}],"balance_after":47012,"source":{"system":"sec-edgar","filing":"0001209191-12-021779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112021779/doc4.xml","form_type":"4"}}],"next_cursor":"2012-04-04T17:37:03.000000Z,194447"}